Participate in research Take part Take part in research studies and surveys currently taking place in Australia. Research advertised below is provided as a service to the diabetes research community. This research is not specifically endorsed by 黑料网. If you would like to promote a survey or ask for participants, email [email protected]. New weight loss study for people living with type 2 diabetes This Phase 3 clinical study is exploring how a once-weekly investigational injectable medicine affects the body over time in adults living with type 2 diabetes and obesity or who are overweight. To be eligible, you must be: aged 18 years or older living with type 2 diabetes living with obesity or are overweight not currently taking a GLP-1 Eligible participants will attend regular clinic visits for health checks, blood tests, and monitoring of blood glucose and weight over a period of 84 weeks, with reimbursement provided. For more details, visit: Research trial: The best way to support older adults with chronic health conditions who feel socially isolated Macquarie University is offering a free online program to help teach skills for managing the impacts of chronic physical health conditions, including how it affects emotional wellbeing and day-to-day functioning. The course consists of online lessons and practice exercises, with additional resources and support also available. You may be eligible if you: Are 60 years or over Have a diagnosed chronic physical health condition Experience feelings of loneliness or social isolation Are English speaking Live in Australia This research has been approved by the Macquarie University Human Research Ethics Committee. For more information, contact [email protected] or visit What diabetes prevention and complication interventions should be tested first? A research team from Baker Heart and Diabetes Institute, with funding from a 黑料网 Research Program Coghlan Award, has developed a brand-new, open-source health economic model for diabetes incidence and complications in Australia. The goal is to create a tool that tests preventative interventions, estimates cost-effectiveness by socioeconomic status, and provides the data needed to lobby for better funding. Whether you are living with diabetes, a carer, involved in research, a clinician, or an advocate, we want to hear from you. Take a few minutes to have your say: This project has ethics approval as part of the 2025 Coghlan Award. Kellion Victory Medallists research study Each year 黑料网 presents the Kellion Victory Medal to those who have lived with type 1 or type 2 diabetes for 50 years or more. As part of our ongoing commitment to invest in research that connects diabetes lived experience with researchers and health professionals, 黑料网 has partnered with researchers around the country to investigate what makes our Kellion Victory Medallists so special. To do this, the research teams need people who have received a Kellion Victory Medal to volunteer to be interviewed and assessed. Find out more: Kellion Victory Medallists research study Chronic health conditions and healthcare Researchers at Macquarie University are seeking participants for a study exploring how people with chronic physical health conditions experience healthcare. People have very different experiences when seeking healthcare, and we鈥檇 like to hear about how your concerns have been understood and responded to. For some, their symptoms are quickly understood. For others, it can be harder to explain what they鈥檙e experiencing, or to feel taken seriously. You may be eligible to take part if you are: Aged 18+ Live in Australia Have a chronic physical health condition The study involves a 15鈥�20 minute online survey. Participants can opt into a prize draw for one of ten $100 gift cards. All responses are de-identified, and participation is entirely voluntary. To take part, visit: This research has been approved by the Macquarie University Human Research Ethics Committee (HREC: 520262034167529). University of Melbourne Research Survey: Type 1 Diabetes and Exercise Support Researchers at the University of Melbourne are inviting people to take part in a research survey about a future chatbot designed to support exercise management in Type 1 Diabetes (T1D). We welcome responses from people who are connected to T1D in any of the following ways: You live with T1D You care for or support someone living with T1D (for example, as a parent, partner, or family member) You work in or conduct research related to T1D (for example, as a clinician, diabetes educator, healthcare professional, or researcher) The survey is voluntary and anonymous, and takes approximately 5鈥�15 minutes to complete. Survey link: Diabetes and the early detection of pancreatic cancer pilot study – GP referrals Could screening people with newly diagnosed diabetes help detect pancreatic cancer earlier? The PaCNOD Pilot Study is a step towards answering this question. Researchers at QIMR Berghofer are looking for GPs to refer patients with new-onset diabetes to the PaCNOD Pilot Study. Find out more: Diabetes and the early detection of pancreatic cancer pilot study Very occasionally diabetes can be an early sign of pancreatic cancer. Scientists at QIMR Berghofer plan a large study to work out whether doing a contrast CT scan of the pancreas in some people with diabetes would be beneficial. You may be required to undertake a survey, with some also required to undertake a contrast CT scan, with gift cards awarded to those who complete these requirements. For more information contact [email protected] or visit Weight management for adults with type 2 diabetes This clinical trial investigates on Weight Reduction in Adult with Obesity or Overweight and with Type 2 Diabetes. The study duration will be less than a year (50 weeks), with clinic visits up to 12 times. Once enrolled in the clinical trial, participants will receive active monotherapy, combined or placebo. You may be able to join the study if you: are between 18 and 75 years of age have been diagnosed with type 2 diabetes for at least 6 months have an HbA1c 鈮�7.5% (58 mmol/mol) to 鈮�10.5% (91 mmol/mol) have been treated with any of the following, alone or in combination, for at least 3 months diet and exercise stable dose of metformin SGLT2 inhibitor not on GIP/GLP-1 RA within the last 6 months and insulin within the last 1 year not on weight loss medication within 6 months. For more information on the study from any of these sites, please contact the following site: QLD Brisbane CORE Research Group; Daunte Tamaki [email protected] Cornerstone Dermatology; Margaret Anders [email protected] Sunshine Coast CDH Research Institute Pty Ltd; Juliette Neve [email protected] NSW Sydney Momentum Darlinghurst; Gloria Lee [email protected] Emeritus Sydney [email protected] VIC Melbourne Emeritus Camberwell [email protected] Sunshine Momentum Sunshine; Luis Camacho [email protected] & Vishwa Patel [email protected] & Dr. King Cheung [email protected] This study has been approved by Bellberry HREC Ethics Approval ID: 2025-08-1363 Complementary medicines and nutritional supplementation use in young people with type 1 diabetes Western Sydney University is undertaking research into how and why young people diagnosed with type 1 diabetes use complementary medicine and nutrient supplementation to manage their condition. They would like to hear from you if: You are 12-25 years old Are considered at risk of developing T1D (e.g., family history, autoantibody positive) OR have been diagnosed with T1D Currently living in Australia To take part, visit: For more information about this study, you can contact: Dr Phoebe Zhou: [email protected]Dr Catharine Fleming: [email protected] Safeguard Study – Australasian type 1 diabetes immunotherapy collaborative The is now looking for people aged 16 – 40 who have recently been diagnosed with type 1 diabetes. This study is testing a new treatment that aims to protect the body’s ability to make insulin. Participants will receive either the study treatment or a placebo (a treatment with no medicine). Who can get involved: People aged between 16 and 40 Recently diagnosed with type 1 diabetes (within 100 days) Living in Victoria, New South Wales or New Zealand Study visits: The treatment is given as a two-day infusion, twice over six months. Participants will be monitored for 12 months, at six clinic visits. Participants will receive reimbursement for their travel. Phone: +61 3 9231 2502 Email: [email protected] Developing a digital tool to improve inpatient hospital diabetes care Researchers from the Tasmanian Health Service and University of Tasmania are looking for people living with diabetes who鈥檝e recently been admitted to hospital to take part in a study. The project aims to develop a digital tool that helps identify people with diabetes who may be at higher risk of health issues during their hospital stay. Your participation involves a 60-minute online discussion led by a researcher, together with 3-7 other people with diabetes, or a one-on-one online interview with a researcher. If you鈥檙e interested in taking part or have any questions, you can find more information at: Share your views on using AI to help screen for diabetes-related kidney disease (DRKD) Researchers at Deakin University are exploring how people living with type 2 diabetes feel about using AI to help screen for diabetes-related kidney disease (DRKD). Adults (aged 18+) with type 2 diabetes are invited to take part in a 5-10 minute survey about how AI could be used to predict the future risk of diabetes-related kidney disease. For more details, or to express your interest in taking part, please visit: Understanding the experiences of young adults with chronic health conditions Share your experience and help improve support services for others. Researchers from Macquarie University are conducting an anonymous online survey to better understand the lived experiences, support needs, and treatment barriers faced by young adults living with chronic physical health conditions in Australia. You may be eligible if you: Are 18 to 29 years old Have a chronic physical health condition (lasting 6+ months) that has been or is currently being managed by a healthcare professional Can read and write in English After completing the full survey, you can enter a draw to win 1 of 4 $50 gift cards. Your participation is anonymous and completely voluntary. Ready to take part? Visit: For more information, contact: Nicole Harte (PhD Candidate) 鈥� [email protected] Approved by MQ HREC (no. 520251942563583) Clinical study of a potential new treatment for non-proliferative diabetic retinopathy (NPDR) The SeeClear Study is looking to better understand a potential new treatment for non-proliferative diabetic retinopathy (NPDR). It is hoped that this investigational treatment can help reduce the symptoms of NDPR and may also stop disease progression. Your participation in the SeeClear Study may help to test how effective this treatment is and will help to gain more information about the safety and how well-tolerated this treatment is in patients with NPDR. You or someone you care for may be able to take part if you/they: Are 18 years of age or older Have Type 1 Diabetes or Type 2 Diabetes Have non-proliferative diabetic retinopathy (NPDR) To learn more about the SeeClear Study, please contact: Sydney Eye Hospital, 8 Macquarie St, Sydney NSW 2000; email: helen.jeong@sydney .edu.au University of the Sunshine Coast Clinical Trials, Level 1/9 Ochre Way, Sippy Downs QLD 4556; phone: 07 5409 8640 Eye Clinic Albury Wodonga,1/669 Dean St, Albury NSW 2640; email: CByrne@ alburyeye.com.au Sydney Retina Clinic, 187 Macquarie St, Sydney NSW 2000; email: lchen@ sydneyretina.com.au Marsden Eye Specialists, 152 Marsden Street; Parramatta, NSW 2150; email: trish.forsyth@ marsdeneye.com Sydney West Retina, The Ashley Centre, Level 2, suite 34/1A Ashley Ln, Westmead NSW 2145; email: [email protected] Retina and Eye Consultants Level 3/33 Macmahon St, Hurstville NSW 2220; email: Julie.Coppock@ retinaandeye.com.au Royal Adelaide Hospital, Port Rd, Adelaide SA 5000; email: kylie.dansie@ sa.gov.au Cardiometabolic conditions – Epworth ENDCAM Study The is recruiting participants to participate in their ENDCAM research study. They are looking for people: 18 – 45 years old living in Australia are female or assigned female at birth are living with type 2 diabetes or other cardiometabolic condition have seen a doctor within the last 12 months To participate, visit: MT-101-101 trial for type 1 diabetes The MT-101-101 study is a phase 1 clinical trial (first-time in humans). It will test the safety and dosing of a new treatment for autoimmune diseases, including type 1 diabetes. The trial treatment is designed to stop or reduce the immune attack on the pancreas that causes type 1 diabetes. Initial studies confirmed its safety in individuals without type 1 diabetes; it now needs to be tested in those with type 1 diabetes. The results of this study will assist researchers to determine the optimal dose for future treatments with this drug. Who can get involved in Australia: People aged between 18 and 45 years Diagnosed with type 1 diabetes Currently using insulin (via injections or by pump) Living in Victoria Treatment: People with type 1 diabetes will receive up to three doses of the trial medication through a vein in their arm at 29-day intervals. One dose will be a placebo (a dummy medication), and up to two doses will be the trial medication. Study visits: The study will involve 15-18 visits to the clinic over 6 months. Participants will be compensated for travel expenses. For more information visit: or complete the . Manage your type 2 diabetes with antioxidant supplements Australian Catholic University is recruiting participants for a study exploring whether a personalised antioxidant supplement regimen can help improve blood glucose control in people with type 2 diabetes. By participating, you will contribute to important research that may lead to more tailored and effective strategies for supporting people living with type 2 diabetes. Who can take part? Aged between 18 and 75 years Have a current HbA1c of 6% or higher Not currently using insulin therapy Participants will be asked to take two antioxidant supplements (vitamin C and N-acetylcysteine) for three months and attend five 60-minute study visits at Australian Catholic University in Melbourne, scheduled according to your availability. This study has approval from the ACU Human Research Ethics Committee (2024-3636HC). For more information, please contact Sophie Broome ([email protected]) or click the link to read the participant information letter and find out if you are eligible: Help improve food label knowledge Researchers at CQUniversity are exploring ways to improve food label knowledge and use to help Australians with diabetes make informed food choices and manage blood sugar. This study aims to understand the barriers and enablers in using food labels, with the goal of improving education and tools that support healthier food choices and diabetes management. Who Can Take Part? Adults aged 18+ living in Australia Diagnosed with type 2 diabetes or prediabetes that may take 20-30 minutes about your food label experience. By completing the survey, you can enter the draw to win 1 of 20 x $50 gift vouchers. Exploring Bodily Threat Monitoring as a Transdiagnostic Factor in Chronic Illness Do you have cancer, diabetes, cardiovascular disease, or asthma? Researchers at the University of Sydney are looking for people with any of these health conditions to investigate perceptions of bodily threat in people experiencing chronic health conditions. This research could lead to improved and more targeted health interventions for people living with chronic health conditions. This online study takes 30 minutes. Click the link below for more information and to complete the study! T1D-Plus: Prevention of damage to insulin-producing cells T1D-Plus will test different study treatments that aim to prevent damage to the body鈥檚 insulin-producing cells (known as beta cells) by the immune system. There is evidence to suggest that each study treatment might be helpful on its own. T1D-Plus will determine if being treated with more than one of the study treatments is more effective than just one. Who can get involved in Australia currently: Aged between 18-44 years Type 1 diabetes diagnosed and commenced insulin therapy within the last 6 weeks People living in Victoria Eligible participants will attend a randomisation visit, during which the study medication will be assigned, followed by 7 treatment visits and 3 phone visits, plus an optional clinic visit. The amount of time spent at the clinic at each visit may vary due to the differing tests and checks. Every participant in this trial will receive at least one study treatment. Participants will know which treatment(s) they receive. To register your interest, ask questions, or receive a copy of the information and consent form, please register at or contact the ATIC team at [email protected]. T1D OBTAIN: Protection of insulin-producing cells in people recently diagnosed with type 1 diabetes T1D OBTAIN is testing the safety and effectiveness of a new treatment designed to protect insulin-producing cells in people with recently diagnosed type 1 diabetes, who have commenced insulin therapy. The aim of the trial is to test whether the new treatment can protect the body鈥檚 own insulin production, help manage blood glucose levels, decrease doses of insulin, and if it is safe to take. Who can get involved in Australia currently: People aged between 18 and 35 years Recently diagnosed with type 1 diabetes Started insulin treatment in the past 90 days Live in Victoria, New South Wales or Queensland Participants will be required to attend 10 trial visits to the clinical centre, over approximately 18 months. Participants will receive an injection of an active study drug or placebo once every two weeks for one year. The treatment is given either at the study site or by a nurse at home. Participants will continue using insulin as part of their regular treatment. To register your interest, ask questions, or receive a copy of the information and consent form, please register at or contact the ATIC team at [email protected]. The Wellbeing Equation: How Self-Care and Social Support Influence Subjective Wellbeing in Australians with Type 1 Diabetes You are invited to participate in a study exploring the subjective wellbeing (i.e., quality of life) of Australian adults (aged 18+) diagnosed with type 1 diabetes. We are seeking Australian adults, who have received a type 1 diabetes diagnosis by a medical professional to participate in an anonymous, online study. Take part in our 15-minute survey to provide essential insights that can help shape future support services and resources for individuals with type 1 diabetes. All information is confidential and non-identifiable. This research has been approved by my University鈥檚 Human Research Ethics Committee: Project number – 2025/072. Do you have a child with type 1 diabetes? Researchers at Griffith University and the University of Queensland are undertaking a study to investigate the experiences and needs of parents and siblings of children with type 1 diabetes in Australia. Share your experiences and valuable thoughts by participating in an . The survey aims to better understand factors that are linked to more positive outcomes for siblings of children with chronic health conditions in Australia, along with families鈥� needs and preferences for support. Enter a prize draw to win one of five $50 AUD gift vouchers. For more information contact Kalpana Subasinghe at [email protected]. Ethics approval- Griffith University Ref No: 2024/339GU Ref No: 2024/339 Type 2 diabetes and persistent pain The University of Sydney is currently recruiting participants with type 2 diabetes and persistent pain for a new clinical trial. This trial will test a new online intervention developed to improve pain severity and pain interference. The study involves completing 4 x 10-15 minute online training sessions over two weeks, as well as some pre and post-intervention surveys. This study will take a maximum of 2.5 hours across a 3-month period. Your participation will help contribute to diabetes research, and we will donate $5 to 黑料网 for each person who completes this study. To learn more and get involved, visit or email the research team at [email protected] Nerve health study for people with type 1 or type 2 diabetes This study looks at how GLP-1 medications affect nerve health, using advanced non-invasive testing. You may be eligible if: you have type 1 or type 2 diabetes you are starting or have already started GLP-1 medication, such as Ozempic, Trulicity, Mounjaro or Byetta you can attend 3 visits; baseline, 6 months and 12 months. For more infomation:Dr Indumathi Singh[email protected]0422 495 868 Manage your type 2 diabetes with expert clinical care Join a six-month study to receive one-on-one support from ACU鈥檚 expert dietitians. Learn how your diet can positively impact your type 2 diabetes management, with professional guidance available to you anywhere across Australia. Participants must be aged 18 years or over, have a confirmed type 2 diabetes diagnosis, a current HbA1c of at least 7.0% and not taking insulin. Learn more at Self-management support for type 2 diabetes: Global exploration of patients and health care professionals’ perspectives A study is being conducted to explore the views and experiences of people living with type 2 diabetes and health care professionals (doctors, diabetes nurse-educator, general nurse, dietitians, psychologist, podiatrist and community health workers) over 18 to take part in a study that aims to understand the effectiveness of current diabetes management support strategies and identify barriers and facilitators to effective support mechanisms for diabetes self-management. If you volunteer to participate, you will be provided with a link to complete a survey (15 minutes) and later invited for an interview if interested (30-45 minutes). Please note that participation in the interview is optional, and you may choose to have it conducted via Microsoft Teams rather than by phone. Survey participants will receive a $5 coffee voucher, and interview participants will receive a $20 Amazon online gift voucher Survey links To find out more about the study, please contact Oluwatosin Arojojoye [email protected]This study has received ethics approval from the James Cook University鈥檚 Human Research Ethics Committee (Approval number: H9661). The Flash Study Evaluation Seeking healthcare professionals to participate This study aims to identify the barriers and enablers to the use of continuous glucose monitors by Aboriginal and Torres Strait Islander peoples with type 2 diabetes, and to determine pathways to overcome these barriers. Participation involves one 45-minute semi-structured interview, which will be conducted in-person or online at your preferred time/day. We are seeking healthcare professionals experienced in providing care for Aboriginal and Torres Strait Islander peoples with type 2 diabetes who use continuous glucose monitors. Please contact [email protected] for further information. Wellbeing and type 1 diabetes Seeking young people with type 1 diabetes We understand that living with type 1 diabetes can impact a young person鈥檚 mental health due to the ongoing demands of management. In this program, we want to support you to develop helpful coping skills and boost your resilience. We are seeking young people aged 13-17 years who have been living with type 1 diabetes for at least 6 months to receive an online mental health and wellbeing program; designed by and for teens with type 1 diabetes. For more information, or to complete the expression of interest, visit: You can contact the team at The Kids Research Institute at [email protected] or on +61 493 702 900. Diabetes prediction study The PREDICTION study is looking for participants to help to understand more about diabetes and how to prevent diabetes complications. To apply for this study, you must: have type 1 or type 2 diabetes have been diagnosed after 2016 have been between 15 and 40 when diagnosed. Study participants can do most of what is required for the study from the comfort of their own home. Once selected for the study, you will be asked to attend a local private pathology clinic (at our cost) to get your blood and urine samples collected, and get your blood pressure measured at your local pharmacy. If you are interested in participating or would like further information, visit . You can contact the study team on (03) 8532 1826 or email [email protected]. Help improve preventive health care for people with intellectual disability This study wants to make health action planning better for people with intellectual disability. What is this study about? People with intellectual disability can have poor health. This project wants to make it easy for people with intellectual disability to engage in health action planning with their doctor to take care of theirpreventive health. (e.g., dietary changes, specialist referrals, screening procedures, blood tests). Through our partnership with key groups, this study will communicate with people with intellectual disability, their support networks (paid and non-paid) and health professionals to improve health action planning for people with intellectual disability. We want to learn from the experiences of health care professionals who have provided preventive health care to people with intellectual disability. What will happen if you take part We will ask to you come to an interview or group meeting (called a focus group). We will ask you questions in person, online or on the phone to learn about your experiences. We can communicate with you in a different way if you prefer. The meeting will take about 1 to 2 hours. You will receive a $50 gift card for your participation. Your experiences will be used to help us improve preventive health care for people with intellectual disability. If you have questions, or want to join the study, contact Jack Cooper at [email protected] or on +61 434 182 259. Paratus Clinical – type 2 diabetes and weight loss This clinical trial looks to investigate type 2 diabetes and weight loss. Learn more at If you have difficulty managing your type 2 diabetes whilst on Metformin, and have not had any weight loss medications recently, you might be eligible for a new clinical trial. Eligible participants will visit the clinic up to 12 times with an additional 8 phone visits over approximately 16 months (69 weeks). Once enrolled in the clinical trial, participants will be randomly allocated to receive either the study medicine or Tirzepatide, the comparator. All treatments will be administered by an injection into a fold of skin on the stomach, thigh or upper arm once weekly. This clinical trial is sponsored by Novo Nordisk. Dietary quality, lifestyle and health among Australian adults This project aims to explore the relationships between dietary habits and other health related factors such as demographic and mental health. You are eligible if you are 18 years or over and live in Australia. This study is not for you if you are pregnant or breastfeeding. Phase 1 – an online survey that takes approximately 40 – 60 minutes to compete on each of the three occasions over 12 months. Phase 2 (optional) – one off in-person assessment at the University of Newcastle (Callaghan campus). All phase 1 participants completing both surveys will be entered into the draw to win one of five $100 gift vouchers at each of the three occasions. To complete the online survey visit: Reach out to the study team at [email protected] Type1Screen – Australia鈥檚 National Screening Program for family members Type1Screen is an Australian initiative offering free type 1 diabetes risk screening. The aim of Type1Screen is to identify people at risk of developing type 1 diabetes as early in the disease process as possible before symptoms develop. To be eligible for Type1Screen, individuals must be aged over 2 years and have a family history of type 1 diabetes. How do I get involved? Participation involves a blood test either at a local pathology collection centre or via a test which can be sent to, and done in, the home. Registration is available directly online. . The blood sample goes to a lab in Melbourne and results are sent back within 8 weeks of sample receipt. Those who are found to be antibody-positive will be supported through a national network of diabetes centres and offered further testing to determine their risk of developing diabetes. They will also be offered the opportunity to enter any available prevention studies through the . Further information about Type1Screen is available at the or by following their or Instagram pages @type1screen. For further information email the team at [email protected]. Clinical Trials Connect Clinical Trials Connect (CTC) was established in 2008. CTC is an online participant recruitment website designed to help match members of the Australian community to research opportunities Australia wide, and deliver recruitment solutions to researchers. People can register their interest to participate in trials on the website either as a healthy volunteer or as a patient with an existing medical condition.
